58 results
DEFA14A
ALKS
Alkermes plc
13 Jun 23
Additional proxy soliciting materials
7:08am
Irish corporate entities. The Board benefits from his extensive network within the Irish business and finance community and his familiarity with Irish
DEFA14A
7qqy7ozbap1
7 Jun 23
Additional proxy soliciting materials
5:28pm
DEFC14A
fu5phbj
25 May 23
Proxy in contested solicitation
4:03pm
PRER14A
j4pxi5
19 May 23
Preliminary revised proxy
5:23pm
PREC14A
tgiy mpnbyl0i1o0p7
8 May 23
Preliminary proxy with contested solicitation
4:34pm
DEFC14A
6eifu12
6 Jun 22
Proxy in contested solicitation
5:29pm
PREC14A
lwoy4 sbo
26 May 22
Preliminary proxy with contested solicitation
5:29pm
8-K
EX-99.1
jx754 e2ns
1 Jun 21
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
7:09am